MedPharm, a topical and transdermal drug formulation development company, has opened its new U.S.-based subsidiary, MP Pharma Services, in Research Park Triangle. The company has completed its first client studies on-site following full equipment and process validation.


 
The facility will provide access to MedPharm’s in vitro models to assess new drug candidate libraries and formulation performance through efficacy, target engagement and delivery testing.
 
“Our new laboratories enable pharmaceutical companies to test various topical and transdermal formulations such as creams, gels and sprays for both new and existing drugs” said Professor Marc Brown, co-founder and chief scientific officer. “Over the last 20 years, MedPharm has established an undisputed leadership position in topical and transdermal formulation development. We have built strong relationships with many of the major U.S. pharmaceutical players and this major investment will enable us to provide our clients with an even faster response to their development challenges, whether it is for new chemical entities, reformulation, generics or claim substantiation.”